Immuneering Corp — Director's Dealing 2022

Mar 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2022-03-15

Reporting Person: Feinberg Peter (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-15	Class A Common Stock	P	6667	$6.75	Acquired	11766	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	392242	Indirect
Class A Common Stock	476615	Indirect
Class A Common Stock	115441	Indirect

Footnotes

F1: This transaction was executed in multiple trades through a broker-dealer at a price of $6.75. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at such price.